The marker genes OLR1 and SLC7A7, which were significantly upregulated in LEMS, were validated in clinical samples, suggesting their potential as biomarkers for pancreatic cancer liver metastases. This evidence concerns the gene OLR1 and familial pancreatic carcinoma.